• The Journal of the Korean dental association
• /
• v.53 no.1
• /
• pp.14-27
• /
• 2015

BMPs are multi-functional growth factors which are members of the transforming growth factor-beta super family and their ability is that plays a pivotal roll in inducing bone. About 18 BMP family members have been identified and characterized. Among of them, BMP-2 and BMP-7 have significant importance in bone development. In this case reports, patients of maxillary sinus graft were received who visited LivingWell Dental Hospital. We focused on the results of the surgical intervention. We suggest that new strategy of treatment used to rhBMP-2 and ${\beta}$-TCP scaffold for patients of sinus graft. The purpose of this paper is to give a brief overview of BMPs and to critically review the clinical data currently available on rhBMP-2 and synthetic bone scaffold.

• Journal of Periodontal and Implant Science
• /
• v.35 no.2
• /
• pp.263-269
• /
• 2005

Bone morphogenetic protein(BMP) and platelet-derived growth factor(PDGF) have been demonstrated tostimulate bone formation when applied locally in vivo. To explore whether or not the combined use of BMP and PDGF could have promotive effect and synergic interaction on bone formation in vivo, bone marrow mesenchymal stem cells were treated with BMP-2, PDGF-BB, or BMP-2 plus PDGF-BB, and then these cells were injected into the subcutaneous space on the dorsum of nude mice. The bone formation was evaluated after 12 weeks. Histomorphometric analysis demonstrated that the subcutaneous nodules formed in nude mice contained 25.3% newly formed bone in the BMP-2 treated cells, 14.4% newly formed bone in the PDGF-BB treated cells, and 8.9% newly formed bone in the RMP-2 plus PDGF-BB treated cells. The results showed that the combination of BMP-2 and PDGF-BB had neither a promotive effect nor synergic interact on bone formation in vivo.

• The Korean Journal of Physiology and Pharmacology
• /
• v.20 no.2
• /
• pp.169-175
• /
• 2016

Here, we investigated whether hyperglycemia and/or free fatty acids (palmitate, PAL) affect the expression level of bone morphogenic protein 4 (BMP4), a proatherogenic marker, in endothelial cells and the potential role of BMP4 in diabetic vascular complications. To measure BMP4 expression, human umbilical vein endothelial cells (HUVECs) were exposed to high glucose concentrations and/or PAL for 24 or 72 h, and the effects of these treatments on the expression levels of adhesion molecules and reactive oxygen species (ROS) were examined. BMP4 loss-of-function status was achieved via transfection of a BMP4-specific siRNA. High glucose levels increased BMP4 expression in HUVECs in a dose-dependent manner. PAL potentiated such expression. The levels of adhesion molecules and ROS production increased upon treatment with high glucose and/or PAL, but this eff ect was negated when BMP4 was knocked down via siRNA. Signaling of BMP4, a pro-inflammatory and pro-atherogenic cytokine marker, was increased by hyperglycemia and PAL. BMP4 induced the expression of inflammatory adhesion molecules and ROS production. Our work suggests that BMP4 plays a role in atherogenesis induced by high glucose levels and/or PAL.

• BMB Reports
• /
• v.44 no.7
• /
• pp.446-451
• /
• 2011

The conversion of fibroblasts into osteoblasts requires the activation of key signaling pathways, including the BMP pathway. Although Runx2 is known to be a component of the BMP pathway, the combination of Runx2 and BMP2 has not yet been examined with respect to the conversion of fibroblasts into osteoblasts. Here, human ligamentum flavum (LF) fibroblast-like cells from six patients were tested for their conversion into osteoblasts using adenoviruses expressing Runx2 or BMP2. The forced expression of Runx2 or BMP2 in primary cultured LF cells resulted in a variety of proliferation and differentiation behaviors. Combined treatment of BMP2 plus Runx2 resulted in better osteoblastic differentiation than treatment with either component alone. These results indicate that the Runx2 and BMP2 pathways possess both common and independent target genes. Collectively, Runx2 plus BMP2 mediated efficient conversion of fibroblast-like LF cells into osteoblast-like cells, suggesting the possible use of these components for clinical applications such as spinal fusion.

• Asian Pacific Journal of Cancer Prevention
• /
• v.15 no.17
• /
• pp.7091-7095
• /
• 2014

Background: The study aimed to evaluate the incidence of CpG island promoter methylation of BMP6, a member of the transforming growth factor beta family, in tissue samples from colorectal cancers (CRC) and look for its association with BMP6 expression and clinicopathological correlation. Materials and Methods: Methylation specific PCR for the BMP6 promoter region was performed with 85 frozen tissue samples of CRC and 45 of normal colon. Methylation status of MLH1 was also determined by the same method. Expression of BMP6 was evaluated by immunohistochemistry (IHC), using Allred's scoring system. The methylation status was analyzed against clinical and pathological parameters in CRC. Results: The study revealed BMP6 hypermethylation in 34 of 85 tumor specimens (40%), and 15 out of 45 normal tissue samples from CRC (33%). The incidence of hypermethylation was inversely correlated with IHC score. Allred's scores of 7 or more were correlated with lower frequency of BMP6 hypermethylation (29% compared to 50% in the remaining, p-value 0.049). However, there was no association between hypermethylation status and any clinicopathological parameters. The methylation status of BMP6 was not correlated with that of MLH1, a key methylation determinant in CRC. On survival analysis, there was no significant difference in progress-free survival (PFS) between the cases with and without hypermethylation (2-year PFS 74% and 76%, respectively). Conclusions: CpG island methylation of BMP6 is found in high frequency in CRC and this epigenetic event is associated with suppressed protein expression in the tumor tissue. However, the marker is not associated with tumor progression of the disease.

• Journal of Korean Society of Forest Science
• /
• v.101 no.3
• /
• pp.538-545
• /
• 2012

This study addressed soil disturbances following harvesting as well as soil physical and hydrological properties within three first-order headwater catchments characterized by ephemeral-intermittent streams. Four treatments representing a range of potential Best Management Practices(BMPs) for ephemeral-intermittent streams were used; BMP1, BMP2, clearcut and reference. This study includes 1 year of pre- and post-harvest observations. Results showed that post-harvest disturbances were closely related with harvesting intensity and generally tended to reflect changes in soil physical and hydrological properties following harvest with the except of bulk density and porosity. Forest clearcutting decreased macroporosity and saturated hydraulic conductivity, and increased soil resistence as a result of severe soil disturbances thereby increasing soil erosion. These impacts were reduced by implementing two BMP treatments during harvesting activities. The finding support the use of either BMP treatments for ephemeral-intermittent streams, however, the additional measure of leaving logging debris in BMP2 did not cover enough soil surface to reduce erosion.

• Proceedings of the Korea Water Resources Association Conference
• /
• 2016.05a
• /
• pp.565-565
• /
• 2016

농림부는 농업지역에서 발생하는 비점오염원을 관리하기 위해 다양한 최적관리기법(BMP)에 대해 연구를 수행하여 효과를 검증하였으나 이를 광역 단위로 보급하여 실제 영농지역에서 BMP의 효과를 측정한 연구는 부족한 실정이다. 따라서 본 연구에서는 논 지역을 대상으로 물관리기술(물꼬)과 시비관리기술(완효성 비료) BMP를 보급하고 광역 단위로 BMP의 효과를 측정하고자 하였다. 연구대상지구는 새만금 지역에 위치한 전라북도 부안군 용계리 일대에 위치하고 있으며, 벼농사가 활발하게 이루어지고 있는 지역을 선정하였다. 논에 보급된 BMP의 효과를 측정하기 위해 BMP 참여 농가를 선정하여 물꼬와 완효성 비료를 보급하였으며, 용수로와 배출구 3지점을 선정하여 관개량을 측정하고 유출량을 측정하였다. 또한 관개수와 대조구, 처리구별(대조구, 물꼬, 완효성, 물꼬+완효성) 수질을 분석하여 배출구 별로 단위면적당 오염부하량을 산정하고 이를 통해 대조구 대비 처리구의 저감율을 분석하였다. 분석 결과, 대조구 대비 처리구의 단위면적당 오염부하량의 저감율은 SS 63.6%, BOD 45.5%, $COD_{Mn}$ 26.5%, $COD_{Cr}$ 40.1%, T-N 16.0%, T-P 12.9%, TOC 11.4%로 나타났다. 또한 연구대상지구를 SO#1(완효성 비료 95%, 비참여 농가 5%), SO#2(완효성 비료 2%, 물꼬 8%, 완효성 비료+물꼬 40%, 비참여 농가 40%), SO#M(완효성 비료 96%, 비참여 농가 4%) 3개의 배출구로 구분하여 BMP 보급 효과를 측정한 결과, 대조구 대비 SO#1에서는 수질항목별로 10.6 ~ 85.5%, SO#2는 8.1 ~ 45.9%, SO#M은 10.7 ~ 86.2%의 범위로 저감된 것으로 분석되었으며, 특히 SS의 단위면적당 오염부하 저감율이 가장 큰 것으로 나타났다. 하지만 본 연구는 7월부터 10월까지 측정된 데이터를 활용하여 산정하였기 때문에 써레질, 이앙기간에 발생한 단위면적당 오염부하량은 포함되지 않은 결과이며, 각 배수구역별 유입량의 경우 정확한 측정에 어려움이 있어 전체 관개량 대비 관개 면적을 이용하여 단위면적당 유입량을 산정하였기 때문에 추가적인 연구를 통해 효과를 검증할 필요가 있을 것으로 판단된다.

• Journal of Veterinary Clinics
• /
• v.39 no.6
• /
• pp.302-310
• /
• 2022

Recently, in human medicine and veterinary medicine, interest in synthetic bone graft is increasing. Among them, bone morphogenic protein (BMP) is currently being actively researched and applied to clinical trials. However, BMP has the disadvantage of being expensive and easily absorbed into surrounding tissues. Therefore, BMP requires the use of small amounts and rhBMP (recombinant human bone morphogenetic protein)-2 carriers that can be released slowly. Hydrogel has the property of swelling a large amount of water inside when it is aqueous solution, and when it is, it consists of more than 90 percent water. Using these properties, hydrogels are often used as rhBMP-2 carrier. The scaffold used in this study is a hydrogel made from which keratin is extracted using human hair and based on it. In this study, we wanted to see the effect of bone formation in the calvarial defect model by using keratin-based hydrogel made with human hair as a scaffold. The experiment was conducted by dividing 3 groups a total of 12 mice. Calvarial bone defect is set to all 4 mm diameters. Bone formation was evaluated by using gross evaluation, micro-computed tomography (micro-CT), immunohistochemistry. Groups using keratin-based hydrogel were significantly observed compared to Group 1s, and the most bone formations were found when rhBMP-2 and hydrogel were used. This represents the superiority of the functions of the rhBMP-2 carrier by a new material, keratin-based hydrogel. Through gross evaluation, micro-CT, and immunohistochemistry, we can confirm that keratin-based hydrogel is a useful rhBMP-2 carrier.

• Journal of Periodontal and Implant Science
• /
• v.53 no.6
• /
• pp.429-443
• /
• 2023

Purpose: The aim of this study was to determine 1) the bone-regenerative effect of porcine bone block materials with or without collagen matrix incorporation, 2) the effect of a collagen barrier, and 3) the effect of adding recombinant human bone morphogenetic protein-2 (rhBMP-2) to the experimental groups. Methods: Four treatment modalities were applied to rabbit calvaria: 1) deproteinized bovine bone mineral blocks (DBBM), 2) porcine bone blocks with collagen matrix incorporation (PBC), 3) porcine bone blocks alone without collagen matrix incorporation (PB), and 4) PBC blocks covered by a collagen membrane (PBC+M). The experiments were repeated with the addition of rhBMP-2. The animals were sacrificed after either 2 or 12 weeks of healing. Micro-computed tomography (micro-CT), histologic, and histomorphometric analyses were performed. Results: Micro-CT indicated adequate volume stability in all block materials. Histologically, the addition of rhBMP-2 increased the amount of newly formed bone (NB) in all the blocks. At 2 weeks, minimal differences were noted among the NB of groups with or without rhBMP-2. At 12 weeks, the PBC+M group with rhBMP-2 presented the greatest NB (P<0.05 vs. the DBBM group with rhBMP-2), and the PBC and PB groups had greater NB than the DBBM group (P>0.05 without rhBMP-2, P<0.05 with rhBMP-2). Conclusions: The addition of rhBMP-2 enhanced NB formation in vertical augmentation using bone blocks, and a collagen barrier may augment the effect of rhBMP-2.

• Journal of Dental Rehabilitation and Applied Science
• /
• v.40 no.1
• /
• pp.13-23
• /
• 2024

Purpose: This aim of this study was to demonstrate growth factors that differentiate human mesenchymal stem cells into chondrocytes and to evaluate cell proliferation enhancement by needle size differences. Materials and Methods: Human mesenchymal stem cells were cultured in chondrogenic medium supplemented with BMP-2, BMP-4, BMP-6, BMP-7, BMP-13, FGF-2, FGF-18, IGF-1, TGF-β1, TGF-β2, TGF-β3 and without growth factors for 14, 21, and 28 days. Then, the expression levels of SOX-5, SOX-6, SOX-9 and FOXO1A were comparatively analyzed. Human mesenchymal stem cells were inoculated into culture dishes using 18, 21, and 26 gauge (G) needles, and cell proliferation was measured after 24, 48, and 72 hours, respectively. Results: In addition to the previously known FGF, IGF-1, and TGFβ1,the BMP family growth factors such as BMP-2, BMP-4, BMP-6, and BMP-7 increased the expression of chondrocyte differentiation genes SOX-5, SOX-6, SOX-9, and FOXO1A. At 48 hours, the 26G group, the smallest needle, showed significant cell proliferation improvement compared to the control group and the 18G group. At 72 hours, the 26G group, the smallest needle, showed significant increase in cell proliferation compared to the control group. Conclusion: Through this study, growth factors with the ability to induce chondrocyte differentiation of human mesenchymal stem cells were investigated, and cell proliferation changes by needle size differences were determined.